Compare BIO & KT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | KT |
|---|---|---|
| Founded | 1952 | 1981 |
| Country | United States | South Korea |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Telecommunications Equipment |
| Sector | Industrials | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 10.2B |
| IPO Year | N/A | 2002 |
| Metric | BIO | KT |
|---|---|---|
| Price | $265.66 | $21.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $358.50 | N/A |
| AVG Volume (30 Days) | 237.8K | ★ 1.9M |
| Earning Date | 04-30-2026 | 02-10-2026 |
| Dividend Yield | N/A | ★ 2.35% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | N/A |
| Revenue Next Year | $3.05 | $1.97 |
| P/E Ratio | ★ $9.72 | $15.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $16.25 |
| 52 Week High | $343.12 | $24.58 |
| Indicator | BIO | KT |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 45.84 |
| Support Level | $239.33 | $21.51 |
| Resistance Level | $289.61 | $24.58 |
| Average True Range (ATR) | 7.68 | 0.57 |
| MACD | 0.48 | -0.20 |
| Stochastic Oscillator | 24.82 | 26.04 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
KT is South Korea's largest fixed-line telecom operator, with around 11.5 million fixed-line broadband customers and 9.5 million IPTV customers, and is the second-largest wireless operator with 28 million subscribers. Additionally, it has a number of nontelecom businesses, including real estate, payment processing, artificial intelligence, and IDC/cloud services, many of which are the focus of its growth strategy. The company was formed from the previously government-owned, monopoly telecom business and was listed in 1998. After selling its mobile business in 1994 (forming its mobile competitor, SK Telecom), KT created its own mobile operator in 1997.